Iq Life Sciences - Due diligence report
A 360° intelligence report on Iq Life Sciences: trust score, financial health, credit view, compliance, directors, growth and distress signa…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Iq Life Sciences — 360° Intelligence Report
Generated from MCA filings & public recordsIq Life Sciences is assessed as Moderate with a Trust Score of 64/100. Iq Life Sciences is an active private not for profit company incorporated in 2012, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 16 Oct 2026 from the latest processed filings. Iq Life Sciences snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2024 - filings overdue.
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PRADEEP YOHANNE GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJU KANOJIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
As per FY 2023 annual returnPromoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 50 · Distress 60Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 8 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| VIAN INFRASTRUCTURE LIMITED | U70109DL2006PLC152025 | South Delhi, Delhi |
| Promion Techno Services Private Limited | U74140DL2013PTC255893 | Delhi |
| Indo Copters Private Limited | U62100DL2005PTC132524 | Delhi |
| MONSOON GLOBAL LIMITED | U52100DL2012PLC244354 | South Delhi, Delhi |
| Allfleet India Private Limited | U63030DL2022PTC399328 | Delhi |
| Kds Jewellers Private Limited | U27100DL2013PTC254350 | Delhi |
| Pegasus Technik Private Limited | U35303DL2000PTC107027 | Delhi |
| Schneider Prototyping India Private Limited | U29219DL2012FTC233842 | Delhi |
| S.R. Texknit Private Limited | U18101DL2006PTC150187 | South Delhi, Delhi |
| Luxe Craftile Private Limited | U26933DL2005PTC133817 | Delhi |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Iq Life Sciences before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Iq Life Sciences: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Limited indicators at present. Growth score 50/100, margin trends, ownership structure and peer set for Iq Life Sciences - screening before a deeper diligence.
Vendor verdict: Review suggested. Trust score 64/100, distress signals and MSME payment-delay disclosures - know whether Iq Life Sciences pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Iq Life Sciences - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Iq Life Sciences an active company?
Iq Life Sciences has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Iq Life Sciences financially healthy?
Iq Life Sciences has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Iq Life Sciences?
Its overall Trust Score is 64/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Iq Life Sciences?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Iq Life Sciences have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Iq Life Sciences up to date with its ROC filings?
Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Iq Life Sciences?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.